Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Budak-Alpdogan, T.
Right arrow Articles by Akoglu, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Budak-Alpdogan, T.
Right arrow Articles by Akoglu, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 37, 1148-1151, Copyright © 1998 by British Society for Rheumatology

ORIGINAL PAPERS

Skin hyperreactivity of Behcet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders

T Budak-Alpdogan, , O Alpdogan, H Direskeneli, T Ergun, A Ozturk, A Gunay, S Yavuz, N Uskent and T Akoglu
TUBITAK, Department of Haematology, Marmara Medical School, Istanbul, Turkey.

Typical manifestations of Behcet's disease (BD) and a positive pathergy reaction were observed in a few patients with chronic myeloid leukaemia (CML) on interferon alpha (IFN-alpha) therapy and the significance of this observation was assessed in a prospective study. The skin pathergy test was applied to 15 patients with CML prior to IFN-alpha therapy, 29 patients with CML following IFN-alpha therapy and 30 patients with BD. Twenty-five patients with inflammatory arthropathies (IA), 20 patients with recurrent oral ulcers (ROU), 23 patients treated with IFN-alpha for various disorders and 20 normal individuals were also studied as control groups. The pathergy reaction was positive in nearly a quarter of IFN-alpha-treated CML cases (24%) as well as one-half of the patients with BD (50%). All CML patients prior to IFN-alpha treatment and all patients using IFN-alpha for other diseases were negative for the pathergy reaction. These results may indicate a similarly altered neutrophil function in both BD and IFN-alpha-treated CML patients.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. Melikoglu, S. Uysal, J. G. Krueger, G. Kaplan, F. Gogus, H. Yazici, and S. Oliver
Characterization of the Divergent Wound-Healing Responses Occurring in the Pathergy Reaction and Normal Healthy Volunteers
J. Immunol., November 1, 2006; 177(9): 6415 - 6421.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
I. A Burney, T. Moatter, T. Siddiqui, and N. Yaqoob
Pathergy in non-Hodgkin lymphoma
J R Soc Med, March 1, 2003; 96(3): 127 - 129.
[Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
V Kontogiannis and R J Powell
Behcet's disease
Postgrad. Med. J., October 1, 2000; 76(900): 629 - 637.
[Abstract] [Full Text]

Home page
 Rheumatology (Oxford)Home page
C. G. Barnes and H. Yazici
Behcet's syndrome
Rheumatology, December 1, 1999; 38(12): 1171 - 1174.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.